Genetically modified microorganisms and fermentation processes for the production of D-allulose
By genetically engineering Kluyveromyces macrocarpa cells, deleting the PFK1 gene, and introducing allulose-6-phosphate phosphatase and epimerase, the problems of low efficiency and high cost in the production of D-allulose in existing technologies have been solved, and efficient and sustainable D-allulose production has been achieved.
Patent Information
- Application Number
- CN202580020802.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-11-26
- Filing Date
- 2025-03-18
- Publication Date
- 2026-11-17
AI Technical Summary
Existing methods for producing D-allulose are costly and inefficient, and it is difficult to effectively separate D-allulose from residual fructose.
By using genetically engineered Kluyveromyces maculae cells, the natural phosphofructokinase-1 (PFK1) gene was deleted, and a foreign polynucleotide sequence encoding allulose-6-phosphate phosphatase and allulose-6-phosphate 3-epimerase was introduced. The production of D-allulose was then regulated by a heterologous promoter and terminator.
It enables the efficient production of D-allulose, with a yield of at least 5 g/L or 10 g/L, providing a cost-effective and sustainable production alternative.
Smart Images

Figure CN123125325A_ABST
Abstract
Description
[0001] Cross-references to related applications
[0002] This application claims the benefits of U.S. Provisional Application No. 63 / 568,003, filed March 21, 2024, and U.S. Provisional Application No. 63 / 724,934, filed November 26, 2024, each of which is incorporated herein by reference in its entirety.
[0003] Refer to the sequence list submitted through the Patent Center
[0004] The contents of the sequence list XML file named "PT-2052-WO-PCT.xml", which was created on March 14, 2025 and submitted electronically with this application via the Patent Centre, and is 438,925 bytes in size, are incorporated herein by full reference. Background Technology
[0005] D-allulose (also known in the art as D-psicose) is a low-calorie sweetener used as a food additive and sugar substitute. Commercially used in beverages, yogurts, ice cream, baked goods, and other typically high-calorie items, D-allulose has 70% the sweetness of sucrose, but its calorific value is approximately 0.2 kcal / g to 0.4 kcal / g compared to 4 kcal / g sucrose. D-allulose is metabolized very little and is essentially unchanged upon excretion, resulting in a very low glycemic index. D-allulose is naturally found in small amounts in figs, raisins, and maple syrup, leading to its designation as a "rare sugar." D-allulose is also associated with certain functional benefits, such as taste, browning ability, and freezing point, allowing it to be used as a sugar substitute in many food and beverage applications.
[0006] Current methods for producing D-allulose include the metaisomerization of fructose from corn starch and beet sugar. However, these methods are expensive due to low reaction yields and the need to separate D-allulose from residual fructose in the reaction mixture. In contrast, fermentation processes are already commercially available on a large scale for producing other organic molecules such as ethanol, citric acid, and lactic acid, and can provide a cost-effective and sustainable alternative to current D-allulose production methods. Therefore, this paper presents genetically modified microorganisms and fermentation methods for the production of D-allulose. Summary of the Invention
[0007] This disclosure provides a genetically engineered *Kluyveromyces marxianus* cell capable of producing D-allulose, the engineered cell comprising the deletion or disruption of the natural phosphofructokinase-1 (PFK1) gene; an exogenous polynucleotide sequence encoding at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical allulose-6-phosphate phosphatase to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, 115, 83, 95, 113, 117, 119, 121, 127, 131, 137, 145, 169, 173, 179, and 183; and ...5%, at least 97%, at least 99%, or 100% identical allulose-6-phosphate phosphatase to at least one of The exogenous polynucleotide sequence of allulose-6-phosphate 3-epimerase may be at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO: 192, 194, and 196. Allulose-6-phosphate phosphatase may be at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, and 115. Allulose-6-phosphate phosphatase may be at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO:87, 89, and 105.Allulose-6-phosphate 3-epimerase is at least 80%, at least 85%, or at least 90% identical to at least one of SEQ ID NO: 192, 194, and 196. Allulose-6-phosphate phosphatase is at least 80%, at least 85%, or at least 90% identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, and 115. Allulose-6-phosphate 3-epimerase is at least 80%, at least 85%, or at least 90% identical to at least one of SEQ ID NO: 192, 194, and 196. Allulose-6-phosphate phosphatase is at least 80%, at least 85%, or at least 90% identical to at least one of SEQ ID NO: 87 and 89.
[0008] Allulose-6-phosphate 3-epimerase may be at least 80%, at least 85%, at least 90%, or at least 95% identical to at least one of SEQ ID NO: 192, 194, and 196, allulose-6-phosphate phosphatase may be at least 80%, at least 85%, at least 90%, or at least 95% identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, 115, 83, 95, 113, 117, 119, 121, 127, 131, 137, 145, 169, 173, 179, and 183, and the cell may be capable of producing at least 5 g / L of allulose.
[0009] Allulose-6-phosphate 3-epimerase may be at least 80%, at least 85%, at least 90%, or at least 95% identical to at least one of SEQ ID NO: 192, 194, and 196, allulose-6-phosphate phosphatase may be at least 80%, at least 85%, at least 90%, or at least 95% identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, and 115, and the cell may be capable of producing at least 10 g / L D-allulose.
[0010] In the cells described herein, one or more exogenous polynucleotide sequences are operatively linked to a heterologous promoter and / or a heterologous terminator. The promoter can be selected from the group consisting of the following: pyruvate decarboxylase promoter (PDCp), translation elongation factor 2 promoter (TEF2p), SED1 promoter, alcohol dehydrogenase 1A promoter (ADH1p), hexokinase 2 promoter (HXK2p), FLO5 promoter, pyruvate kinase 1 promoter (PYK1p); 6-phosphogluconic acid dehydrogenase promoter (6PGDp); glyceraldehyde-3-phosphate dehydrogenase promoter (TDH3p); translation elongation factor 1 promoter (TEFp); phosphoglucose mutase 1 promoter (PGM1p); 3-phosphoglycerate kinase promoter (PGK1p); enolase promoter (ENO1p); asparagine synthase promoter (ASNSp); 50S ribosomal protein L1 promoter (RPLAp); RPL 16B; and PDC1 promoter. The terminator can be selected from the group consisting of the following: GAL10 terminator, PDC terminator, transaldolase terminator (TAL), 6PGD terminator (6PGDt); ASNS terminator (ASNSt); ENO1 terminator (ENOlt); hexokinase 1 terminator (HXK1t); PGK1 terminator (PGK1t); PGM1 terminator (PGM1t); PYK1 terminator (PYK1t); RPLA terminator (RPLAt); transaldolase 1 terminator (TAL1t); TDH3 terminator (TDH3t); translation elongation factor 2 terminator (TEF2t); triose phosphate isomerase 1 terminator (TPI1t); TEF1; iso-1-cytochrome c terminator (CYC1); HXK2 terminator; GPM1 terminator; URA3 terminator; ADH1 terminator; and ScGAL10 terminator.
[0011] This disclosure also provides a method for producing D-allulose, the method comprising contacting a substrate with engineered cells as described herein, wherein the engineered cells produce at least 1.0 g / L, at least 5.0 g / L, at least 10.0 g / L, or at least 15 g / L after 72 hours. The substrate may include starch, glucose, cellulose biomass, or combinations thereof.
[0012] This disclosure also provides the use of engineered cells, as described herein, for the production of D-allulose. Attached Figure Description
[0013] This patent or application contains at least one color-drawn drawing. A copy of this patent or patent application publication with a color drawing will be provided by the Patent Office upon request and payment of the necessary fees.
[0014] The accompanying figures illustrate, in a manner that is not restrictive, various aspects described herein.
[0015] Figure 1 A recommended pathway for producing D-allulose from sucrose, starch, and / or glucose is shown. Detailed Implementation
[0016] Reference will now be made in detail to certain aspects of the subject matter disclosed herein, examples of which are partially illustrated in the accompanying drawings. While the disclosed subject matter will be described in conjunction with the enumerated claims, it should be understood that the illustrated subject matter is not intended to limit the claims to the disclosed subject matter.
[0017] In this document, unless the context clearly requires otherwise, the terms "an," "a," or "the / described" are used to include one or more. Unless otherwise indicated, the term "or" is used to mean a non-exclusive "or." All publications, patents, and patent documents cited in this document are incorporated herein by reference in their entirety as if individually cited. In the event of any inconsistency between the usage of this document and those documents so incorporated by reference, the usage in the incorporated references shall be considered supplementary to the usage in this document; in the case of irreconcilable inconsistencies, the usage in this document shall prevail.
[0018] Values expressed in range format should be interpreted flexibly to include not only the values explicitly listed as limits of the range, but also all individual values or subranges covered within the range, as if each value and subrange were explicitly listed. For example, a range of "about 0.1% to about 5%" or "about 0.1% to 5%" should be interpreted to include not only about 0.1% to about 5%, but also individual values (e.g., 1%, 2%, 3%, and 4%) and subranges (e.g., 0.1% to 0.5%, 1.1% to 2.2%, 3.3% to 4.4%) within the specified range. Unless otherwise stated, the statement "about X to Y" has the same meaning as "about X to about Y". Similarly, unless otherwise stated, the statement "about X, Y, or about Z" has the same meaning as "about X, about Y, or about Z".
[0019] Unless otherwise specified, ppm (parts per million), percentages, and ratios are based on weight. Percentages based on weight are also referred to below as weight% or (weight)%.
[0020] This disclosure relates to various recombinant cells engineered to produce D-allulose. Generally, the recombinant cells described herein comprise allulose-6-phosphate 3-epimerases encoding at least one of SEQ ID NO: 192, 194, and 196 or allulose-6-phosphate 3-epimerases having a sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to the sequence thereon. The recombinant cells may additionally include a heterologous nucleic acid encoding allulose-6-phosphate phosphatase, such as at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, 115, 83, 95, 113, 117, 119, 121, 127, 131, 137, 145, 169, 173, 179, and 183, or an allulose-6-phosphate phosphatase having a sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to that sequence. This disclosure also provides a fermentation method for producing D-allulose using the genetically engineered cells described herein.
[0021] As used herein, “D-allulose” and “allulose” are used interchangeably and refer to the hexulose epimer of fructose as shown in Structure I below. D-allulose is also referred to in the art as “D-pseudofructose” or “pseudofructose”. D-allulose is present in trace amounts in wheat, figs, raisins, maple syrup, and molasses, leading to its designation as a rare sugar.
[0022]
[0023] Generally, the recombinant cells described herein are Kluyveromyces maxlausii cells. Suitable Kluyveromyces maxlausii cells and strains are known and described in the art. Those skilled in the art can identify strains suitable for generating the recombinant cells described herein. Kluyveromyces maxlausii cells may be commercially available cells.
[0024] Unless otherwise expressly stated, the terms “glucose” and “dextrose” are used interchangeably in this document and refer to D-glucose.
[0025] The recombinant cells described herein contain one or more exogenous polynucleotide sequences encoding one or more exogenous polypeptides that, when expressed, enable the recombinant cells to produce D-allulose.
[0026] As used herein, "exogenous" refers to genetic material or its expression product originating outside the host organism. For example, exogenous genetic material or its expression product can be a modified form of the host organism's natural genetic material, it can originate from another organism, it can be a modified form of a component derived from another organism, or it can be a component of synthetic origin. For example, when introduced into *Saccharomyces cerevisiae*, the lactate dehydrogenase gene from *Lactobacillus helveticus* is exogenous.
[0027] As used in this article, “natural” refers to genetic material or its expression products found in the genome of wild-type cells of a host cell, except for inter-individual mutations that do not affect function or expression.
[0028] For the purposes of this application, the *Kluyveromyces martensii* CD21 cells deposited on October 18, 2024, under accession number 58456 at BCCM / MUCL (Belgian Coordinated Collections of Microorganisms / Mycotheque de l'Universite Catholique de Louvain; address: Croix du Sud, box L7.05.06, B-1348 Louvain-la-Neuve, Belgium) are considered wild-type *Kluyveromyces martensii* cells.
[0029] As used herein, the terms “polypeptide” and “peptide” are used interchangeably and refer to the total primary, secondary, tertiary, and quaternary amino acid sequence and structure necessary to give the macromolecule described its function and properties. As used herein, “enzyme” or “biosynthetic pathway enzyme” refers to a protein that catalyzes a chemical reaction. The description of any particular enzyme (independently or as part of a biosynthetic pathway) should be understood to include the cofactors, coenzymes, and metals necessary for the enzyme to function properly. As understood in the art, an overview of amino acids and their three-letter and one-letter symbols is provided in Table 1. Amino acid names, three-letter symbols, and one-letter symbols are used interchangeably herein.
[0030] Table 1: Three-letter and single-letter symbols for amino acids
[0031]
[0032]
[0033] Variants or sequences having substantially the same identity or homology with the polypeptides described herein can be used to carry out the disclosed compositions and methods. Such sequences may be referred to as variants or modified sequences. That is, the polypeptide sequence may be modified but still retain the ability to exhibit the desired activity. Typically, variants or modified sequences may include greater than about 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, or 95% sequence identity with wild-type, naturally occurring polypeptide sequences or with variant polypeptides as described herein.
[0034] As used herein, the phrases “sequence identity %”, “identity %”, and “identity percentage” are used interchangeably and refer to the percentage of residue matches between at least two amino acid sequences or at least two nucleic acid sequences aligned using a normalized algorithm. Methods for amino acid and nucleic acid sequence alignment are well-known. Sequence alignment and sequence identity generation involve both global and local alignments using computational methods. Alignment can be performed using BLAST (National Center for Biotechnology Information (NCBI) Basic Local Alignment Search Tool) version 2.2.31 software with default parameters. The amino acid sequence identity % between amino acid sequences can be determined using the standard protein BLAST with the following default parameters: Maximum target sequence: 100; Short sequence query: Parameters automatically adjusted for short input sequences; Expected threshold: 10; Word length: 6; Maximum number of matches within the query range: 0; Matrix: BLOSUM62; Void penalty: (Presence: 11, Extension: 1); Composition adjustment: Conditional compositional score matrix adjustment; Filtering: Not selected; Masking: Not selected. The standard nucleotide BLAST algorithm with the following default parameters can be used to determine the percentage of nucleic acid sequence identity between nucleic acid sequences: Maximum target sequence: 100; Short sequence query: Automatically adjusts parameters for short input sequences; Expected threshold: 10; Word length: 28; Maximum number of matches within the query range: 0; Match / mismatch score: 1, -2; Gap penalty: Linear; Filtering: Low complexity region; Masking: Mask only the lookup table. Sequences that have an identity score of XX% (e.g., 80%) relative to a reference sequence using the NCBI BLAST version 2.2.31 algorithm with default parameters are considered to be at least XX% identical, or equivalently have XX% sequence identity with the reference sequence.
[0035] Peptide or polynucleotide sequence identity can be measured over the entire length of a defined peptide sequence (e.g., as defined by a specific SEQ ID number) or over a shorter length, such as over a fragment taken from a larger defined peptide sequence (e.g., a fragment of at least 15, 20, 30, 40, 50, 70, or 150 consecutive residues). Such lengths are merely exemplary and it should be understood that any fragment length supported by the sequences shown in this document, tables, figures, or sequence listings can be used to describe the length over which a measurable percentage of identity can be measured.
[0036] The polypeptides disclosed herein may include “variant” polypeptides, “mutants” and “derivatives thereof.” As used herein, the term “wild-type” is a term understood by those skilled in the art and refers to the typical form of the polypeptide in nature, as distinct from the variant or mutant form. As used herein, “variant,” “mutant,” or “derivative” refers to a polypeptide molecule having an amino acid sequence different from that of a reference protein or polypeptide molecule. Variants or mutants may have one or more amino acid residues inserted, deleted, or substituted relative to the reference molecule.
[0037] The amino acid sequences of peptide variants, mutants, derivatives, or fragments covered herein may include conserved amino acid substitutions relative to a reference amino acid sequence. For example, variant, mutant, derivative, or fragment peptides may include conserved amino acid substitutions relative to a reference molecule. A “conserved amino acid substitution” is one in which an amino acid is substituted for a different amino acid, wherein the substitution is predicted to have minimal interference with the properties of the reference peptide. In other words, a conserved amino acid substitution substantially preserves the structure and function of the reference peptide. Conserved amino acid substitutions typically maintain (a) the structure of the peptide backbone in the substitution region, such as a β-sheet or α-helical conformation, (b) the charge and / or hydrophobicity of the molecule at the substitution site, and / or (c) the bulk portion of the side chains.
[0038] As used herein, the terms “polynucleotide,” “polynucleotide sequence,” and “nucleic acid sequence” are used interchangeably with “nucleic acid” and refer to a nucleotide sequence or any fragment thereof. These phrases also refer to DNA or RNA of natural or synthetic origin, which may be single-stranded or double-stranded, and may indicate a sense strand or antisense strand. DNA polynucleotides can be cDNA or genomic DNA sequences.
[0039] A polynucleotide is said to encode a polypeptide if, in its natural state or when manipulated by methods known to those skilled in the art, it can be transcribed and / or translated to produce a polypeptide or a fragment thereof. The antisense strand of such a polynucleotide is also considered to encode the sequence.
[0040] Those skilled in the art understand the degeneracy of the genetic code and that multiple polynucleotides can encode the same polypeptide. In some respects, polynucleotides (i.e., polynucleotides encoding non-heme iron-binding protein polypeptides) can be codon-optimized for expression in specific cells, including but not limited to plant cells, bacterial cells, fungal cells, or animal cells. Although polypeptides encoded by polynucleotide sequences found in corals are disclosed herein, any polynucleotide sequence encoding the desired form of the polypeptide described herein can be used. Therefore, sequences that are not naturally occurring can be used. These sequences may be desired, for example, to enhance the expression of polypeptides or proteins in heterologous expression systems. Computer programs for generating degenerate coding sequences are available and can be used for this purpose. Pencils, paper, the genetic code, and artificial manipulation can also be used to generate degenerate coding sequences.
[0041] The recombinant cells described herein may contain deletions or disruptions in one or more natural genes. The phrase "deletion or disruption" refers to the state of a natural gene in the recombinant cell, having a completely eliminated coding region (deletion) or a modification (such as by deletion, insertion, or mutation) of the gene, its promoter, or its terminator, such that the gene no longer produces an active expression product, produces a severely reduced amount of expression product (e.g., at least 75% or at least 90%), or produces a severely reduced expression product (e.g., at least 75% or at least 90%). Deletions or disruptions can be achieved through genetic engineering methods, directed evolution, mutagenesis, RNA interference (RNAi), and / or selection and screening. Deletions or disruptions of natural host cell genes may be coupled with the incorporation of one or more polynucleotide sequences (e.g., exogenous or natural polynucleotide sequences) into the host cell at the locus of the host cell gene to be deleted or disrupted. The polynucleotide sequence to be inserted may be designed to replace all or part of the host cell gene to be deleted or disrupted. The polynucleotide sequence may encode a target gene product, such as a polypeptide, enzyme, etc. Deletions or disruptions may also be accomplished using deletion constructs that do not contain the polynucleotide sequence to be integrated. Other methods for gene disruption or deletion are known and described in the art.
[0042] The recombinant cells described herein may include the deletion or disruption of the native phosphofructokinase-1 (PFK1) gene. The native PFK1 gene encodes an enzyme with phosphofructokinase-1 activity. As used herein, “phosphofructokinase-1 activity” and “PFK1 activity” are used interchangeably and refer to the enzyme that catalyzes the irreversible conversion of β-D-fructose 6-phosphate, adenosine triphosphate (ATP), and inorganic phosphate (Pi) to β-D-fructose 1,6-bisphosphate, adenosine diphosphate (ADP), and water. PFK1 is an enzyme in the glycolysis pathway and is the first irreversible reaction specific to glycolysis. Without being bound by any particular theory, method, or mode of action, when PFK1 activity is reduced or eliminated, more cellular fructose-6-phosphate will be available for the production of D-allulose. When the host cell contains multiple PFK1 genes, deletion or disruption of at least one of them is preferred. When the host cell contains multiple alleles of a given PFK1 gene, it is preferable to delete or disrupt one or two alleles of the given PFK1 gene.
[0043] When the recombinant cells are *Kluyveromyces martensii* cells, the recombinant cells may include the deletion or disruption of the PFK1 gene, which encodes an amino acid sequence that is at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99%, or 100% identical to that in SEQ ID NO:244. When the recombinant cells are *Kluyveromyces martensii* cells, the recombinant cells may include the deletion or disruption of the PFK1 gene, which has a nucleotide sequence that is at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99%, or 100% identical to that in SEQ ID NO:245. When the recombinant cells are *Kluyveromyces martensii* cells, the PFK1 gene may be deleted or disrupted by inserting a foreign or native nucleic acid sequence at the PFK1 locus to replace the PFK1 gene. For example, in Kluyveromyces martensii, the PFK1 locus is flanked by SEQ ID No: 242 and 243.
[0044] The recombinant cells described herein may contain one or more genetic modifications in which exogenous nucleic acids are integrated into the host cell genome. Those skilled in the art know how to select suitable loci in the yeast genome for the integration of exogenous nucleic acids. Suitable integration loci may include, but are not limited to, the PDC1, GPD1, CYB2A, CYB2B, g4240, YMR226, MDHB, ATO2, Adh9091, Adh1202, ADE2, ADH2556, GAL6, MDH1, SCW11, ER1, ER3, pyrF, TRP3, gpdIIA, and gpdIIB loci. For example, in *M. pollinis* host cells, suitable integration loci may include, but are not limited to: the ER1 locus (defined as a locus flanked by SEQ ID NO:247 and SEQ ID NO:248), the ER3 locus (defined as a locus flanked by SEQ ID NO:249 and SEQ ID NO:250), the PDC1 locus (defined as a locus flanked by SEQ ID NO:251 and SEQ ID NO:252), the pyrF locus (defined as a locus flanked by SEQ ID NO:253 and SEQ ID NO:254), the TRP3 locus (defined as a locus flanked by SEQ ID NO:255 and SEQ ID NO:256), the gpdIIA locus (defined as a locus flanked by SEQ ID NO:257 and SEQ ID NO:258); the gpdIIB locus (defined as a locus flanked by SEQ ID NO:259 and SEQ ID NO:260); and the RSCR26640 locus (defined as a locus flanked by SEQ ID NO:259 and SEQ ID NO:260). The loci are SEQ ID NO: 261 and SEQ ID NO: 262. In Kluyveromyces martensii host cells, suitable integration loci may include, but are not limited to, the CYB2 locus (defined as the locus flanking SEQ ID NO: 212 and SEQ ID NO: 213). Exogenous nucleic acids may also be integrated into intergenic regions or other locations in the host cell genome not specifically specified herein. Those skilled in the art can identify other suitable integration loci. Furthermore, those skilled in the art will recognize how sequences can be used to design primers to verify that correct gene integration occurs at the selected locus.
[0045] Recombinant cells may have one or more copies of a given exogenous nucleic acid sequence, which are integrated into the host chromosome and replicate together with the integrated chromosome. For example, yeast cells may be transformed with a nucleic acid construct containing a polynucleotide sequence encoding a polypeptide described herein, and one or more copies of the polynucleotide sequence encoding the polypeptide may be integrated into the host chromosome. Recombinant cells may contain multiple (two or more) copies of a given polynucleotide sequence encoding a polypeptide described herein. Recombinant cells may have one, two, three, four, five, six, seven, eight, nine, ten or more copies of the polynucleotide sequence encoding the polypeptide described herein, integrated into the genome. The multiple copies of the polynucleotide sequence may be incorporated entirely into a single locus or may be incorporated into multiple loci.
[0046] The recombinant cells described herein are capable of producing D-allulose, have a deletion or disruption of the PFK1 gene, and include an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase. The epimerase can be any suitable enzyme with allulose-6-phosphate 3-epimerase activity. The exogenous polynucleotide sequence can be an exogenous allulose-6-phosphate 3-epimerase (epimerase) gene.
[0047] As used herein, "allulose-6-phosphate 3-epimerase gene" refers to any gene or polynucleotide encoding a polypeptide having allulose-6-phosphate epimerase activity. As used herein, "allulose-6-phosphate 3-epimerase activity" refers to the ability to catalyze the conversion of fructose-6-phosphate to allulose-6-phosphate via epimerization at the C3 position of fructose-6-phosphate. Enzymes with allulose-6-phosphate 3-epimerase activity can be cobalt (Co)-containing enzymes. 2+ ), manganese (Mn) 2+ ), calcium (Ca 2+ ), magnesium (Mg) 2+ ) and / or zinc (Zn 2+An enzyme whose activity increases in the presence of allulose-6-phosphate 3-epimerase. Allulose-6-phosphate 3-epimerase can be derived from any suitable biological source or can be synthetic. Suitable allulose-6-phosphate 3-epimerases may include, but are not limited to, enzymes classified under Enzyme Committee (EC) number 5.1.3. Suitable allulose-6-phosphate 3-epimerases may be allulose-6-phosphate 3-epimerases derived from *Escherichia coli*, *Pseudoleptotrichia goodfellowii*, *Blautia glucerasea*, etc. The allulose-6-phosphate 3-epimerase gene may encode at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% of the amino acids identical to at least one of SEQ ID NO: 192, 194, and 196.
[0048] The recombinant cells have a deletion or disruption of the PFK1 gene and may include exogenous polynucleotides that are or may be derived from an E. coli gene encoding the amino acid sequence of SEQ ID NO:192. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:192.
[0049] The recombinant cells have a deletion or disruption of the PFK1 gene and may include an exogenous polynucleotide that is or may be derived from a *Pseudococcus guillier* gene encoding the amino acid sequence of SEQ ID NO:194. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:194.
[0050] The recombinant cells have a deletion or disruption of the PFK1 gene and may include a foreign polynucleotide sequence that is or can be derived from a *Glucosinolates* gene encoding the amino acid sequence of SEQ ID NO:196. The foreign polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:196.
[0051] The recombinant cells described herein are capable of producing D-allulose, having a deletion or disruption of the PFK1 gene, including a foreign polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and optionally including a foreign polynucleotide sequence encoding allulose-6-phosphate phosphatase. Allulose-6-phosphate phosphatase can be any suitable enzyme with allulose-6-phosphate phosphatase activity. The foreign polynucleotide sequence can be a foreign allulose-6-phosphate phosphatase gene.
[0052] As used herein, “alulose-6-phosphate phosphatase” refers to any gene or polynucleotide encoding a polypeptide having allulose-6-phosphate phosphatase activity. As used herein, “alulose-6-phosphate phosphatase activity” refers to the ability to catalyze the hydrolysis of D-alulose-6-phosphate to D-alulose and phosphate ions. Suitable allulose-6-phosphate phosphatases active against hexose-6-phosphate substrates are known and described in the art. Allulose-6-phosphate phosphatases may be derived from any suitable source or may be synthetic. Suitable allulose-6-phosphate phosphatases may include, but are not limited to, those derived from: *Escherichia coli*, *Shewanella algae*, *Tatumella morbirosei*, *Shewanella loihica*, *Ferrimonas sediminicola*, *Shewanella fodinae*, *Parashewanella spongiae*, *Wickerhamomyces ciferrii*, *Trabulsiella odontotermitis*, *Shewanella aestuarii*, *Shewanella pealeana*, *Shewanella sp.*, *Shewanella denitrificans*, and *Shewanella wulliganella*. *Ferrimonas lipolytica*, *Shewanella violacea*, *Shewanella mangrove*, *Parashewanella curva*, *Shewanella frigidimarina*, *Ferrimonas aestuarii*, and *Shewanella* species OPT22. The allulose-6-phosphate phosphatase gene may encode at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% of the amino acids that are identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, 115, 83, 95, 113, 117, 119, 121, 127, 131, 137, 145, 169, 173, 179, and 183.The allulose-6-phosphate phosphatase gene encodes at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% of the amino acids listed in SEQ ID NO: 87, 89, 190, 123, 105, 107, and 115. The allulose-6-phosphate phosphatase gene encodes at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% of the amino acids listed in SEQ ID NO: 87, 89, 105, and 190. The allulose-6-phosphate phosphatase gene encodes at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% of the amino acids listed in SEQ ID NO: 87 and 105.
[0053] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from a Shewanella algae gene encoding the amino acid sequence of SEQ ID NO:87. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:87.
[0054] The recombinant cells have a deletion or disruption of the PFK1 gene, including a foreign polynucleotide sequence encoding allulose-6-phosphate 3-epimerase and having a deletion or disruption of the PFK1 gene, and may include a foreign polynucleotide that is or may be derived from a *Mobirosseta* gene encoding the amino acid sequence of SEQ ID NO:89. The foreign polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:89.
[0055] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or may be derived from an *E. coli* gene encoding the amino acid sequence of SEQ ID NO:190. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:190.
[0056] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from a Shewanella photovoltaicis gene encoding the amino acid sequence of SEQ ID NO:123. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:123.
[0057] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from a *Istrophomonas ferrore-depositing* gene encoding the amino acid sequence of SEQ ID NO:105. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:105.
[0058] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a Shewanella variegata gene encoding the amino acid sequence of SEQ ID NO:107. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:107.
[0059] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from a *Pseudomonas sponge* gene encoding the amino acid sequence of SEQ ID NO:115. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:115.
[0060] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from the Wickham Severus gene encoding the amino acid sequence of SEQ ID NO:83. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:83.
[0061] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from a *Terrabus* gene encoding the amino acid sequence of SEQ ID NO:95. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:95.
[0062] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from a Shewanella estuarine gene encoding the amino acid sequence of SEQ ID NO:113. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:113.
[0063] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a *Shewanella perensis* gene encoding the amino acid sequence of SEQ ID NO:117. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:117.
[0064] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a Shewanella gene encoding the amino acid sequence of SEQ ID NO:119. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:119.
[0065] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a Shewanella denitrifying gene encoding the amino acid sequence of SEQ ID NO:121. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:121.
[0066] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a Shewanella var. wulleri gene encoding the amino acid sequence of SEQ ID NO:127. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:127.
[0067] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or may be derived from a *Ferrodiola cristata* gene encoding the amino acid sequence of SEQ ID NO:131. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:131.
[0068] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or may be derived from a *Shewanella violaceum* gene encoding the amino acid sequence of SEQ ID NO:137. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:137.
[0069] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a Shewanella mangrove gene encoding the amino acid sequence of SEQ ID NO:145. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:145.
[0070] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a *Temminckia sputum* gene encoding the amino acid sequence of SEQ ID NO:149. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:149.
[0071] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a *Pseudomonas brevis* gene encoding the amino acid sequence of SEQ ID NO:169. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:169.
[0072] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide that is or may be derived from a *Shewanella glabrata* gene encoding the amino acid sequence of SEQ ID NO:173. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:173.
[0073] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from the *Ferructus estuarineis* gene encoding the amino acid sequence of SEQ ID NO:179. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:179.
[0074] The recombinant cells have a deletion or disruption of the PFK1 gene, including an exogenous polynucleotide sequence encoding allulose-6-phosphate 3-epimerase, and may include an exogenous polynucleotide sequence that is or can be derived from the Shewanella OPT22 gene encoding the amino acid sequence of SEQ ID NO:183. The exogenous polynucleotide may encode an amino acid sequence that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, or at least 99% identical to SEQ ID NO:183.
[0075] The exogenous nucleic acids in the recombinant cells described herein can be controlled by promoters. For example, the exogenous nucleic acids can be operatively linked to heterologous promoters or artificial promoters. Suitable promoters are known and described in the art. Promoters may include, but are not limited to: pyruvate decarboxylase promoter (PDC), translation elongation factor 2 promoter (TEF2), SED1, alcohol dehydrogenase 1A promoter (ADH1), hexokinase 2 promoter (HXK2), FLO5 promoter, pyruvate kinase 1 promoter (PYK1p); 6-phosphogluconic acid dehydrogenase promoter (6PGDp); glyceraldehyde-3-phosphate dehydrogenase promoter (TDH3p); translation elongation factor 1 promoter (TEFp); phosphoglucose mutase 1 promoter (PGM1p); 3-phosphoglycerate kinase promoter (PGK1p); enolase promoter (ENO1p); asparagine synthase promoter (ASNSp); 50S ribosomal protein L1 promoter (RPLAp); RPL16B (SEQ ID NO: 248); ScPDClp (SEQ ID NO: 220); KmTDH3p (SEQ ID NO: 222).
[0076] The exogenous nucleic acids in the recombinant cells described herein can be controlled by terminators. For example, the exogenous nucleic acids can be operatively linked to heterologous or artificial terminators. Suitable terminators are known and described in the art. Terminators may include, but are not limited to: GAL10 terminator, PDC terminator, transaldolase terminator (TAL), 6PGD terminator (6PGDt); ASNS terminator (ASNSt); ENO1 terminator (ENO1t); hexokinase 1 terminator (HXK1t); PGK1 terminator (PGK1t); PGM1 terminator (PGM1t); PYK1 terminator (PYK1t); RPLA terminator (RPLAt); transaldolase 1 terminator (TAL1t); TDH3 terminator (TDH3t); translation elongation factor 2 terminator (TEF2t); triose phosphate isomerase 1 terminator (TPI1t); TEF1; iso-1-cytochrome c (CYC1; SEQ ID NO: 218); KmHXK2t (SEQ ID NO: 27); KmGPM1t (SEQ ID NO: 221); KmPGK1t (SEQ ID NO: 223); ScURA3t (SEQ ID NO: 223); NO: 217); URA3; ADH1; and ScGAL10.
[0077] If the position of a promoter or terminator relative to the polynucleotide in the genome or expression cassette allows the promoter or terminator (as the case may be) to perform its transcriptional control function, then the promoter or terminator is “operably linked” to the given polynucleotide (e.g., a gene).
[0078] The polynucleotides described herein may be provided as part of a construct. As used herein, the term "construct" refers to a recombinant polynucleotide, including but not limited to DNA and RNA, which may be single-stranded or double-stranded and may represent a sense strand or an antisense strand. Recombinant polynucleotides are polynucleotides formed by laboratory methods and may comprise polynucleotide sequences derived from at least two different natural sources, or they may be synthetic. Therefore, constructs may include novel modifications to endogenous genes introduced, for example, through genome editing technologies. Constructs may also include recombinant polynucleotides produced using, for example, recombinant DNA methodologies. Constructs may be vectors comprising a promoter operatively linked to a polynucleotide encoding an allulose-6-phosphate-3-epimerase. As used herein, the term "vector" refers to a polynucleotide capable of transporting another polynucleotide linked to it. Vectors may be plasmids, which are circular double-stranded DNA loops into which additional DNA fragments may be integrated.
[0079] This disclosure also provides a fermentation method for producing D-allulose using the recombinant cells described herein. The fermentation method includes the step of fermenting a substrate using genetically engineered yeast cells or genetically engineered bacterial cells described herein to produce D-allulose. As will be understood by those skilled in the art, the fermentation method may include additional steps. Non-limiting examples of additional process steps include maintaining the temperature of the fermentation broth within a predetermined range, adjusting the pH during fermentation, and separating ethanol from the fermentation broth.
[0080] Fermentation substrates may include starch. Starch can be obtained from natural sources, such as plants. Starch can also be obtained from feedstocks with high starch or sugar content, including but not limited to corn, sweet sorghum, fruit, sweet potato, rice, barley, sugarcane, sugar beet, wheat, cassava, potato, tapioca, calathea, peas, or sago. Fermentation substrates may be derived from lignocellulosic biomass (such as wood, straw, grass) or algal biomass (such as microalgae and macroalgae). Fermentation substrates may include cellulose or lignocellulosic biomass. Fermentation substrates may be derived from grass, trees, or agricultural and forestry residues, such as corn cobs and corn stalks, straw, sawdust, and wood chips. Fermentation substrates may also include sugars, such as glucose (dextrose) or sucrose, and / or polysaccharides, such as maltodextrin. Fermentation substrates may be pretreated physically (e.g., by heat, pressure, etc.) or chemically (e.g., by acid, hydrolysis, enzymatic treatment, such as glucosylamylase, etc.) before or during the fermentation process.
[0081] The culture medium used for fermenting the engineered cells described herein can be supplemented with various components. For example, the culture medium used for fermenting the engineered cells described herein can be supplemented with glucosylamylase, such as Spirizyme. ™(Novozymes, Bagsvaerd, Denmark) and / or Aspergillus niger from Sigma-Aldrich under the trade name AMG 300L ™ Amylase for sale.
[0082] Fermentation processes can be operated under a variety of conditions. The fermentation temperature (i.e., the temperature of the fermentation broth during processing) can be ambient temperature. Alternatively or additionally, the fermentation temperature can be maintained within a predetermined range. For example, the fermentation temperature can be maintained within the ranges of 25°C to 50°C, 26°C to 45°C, 27°C to 40°C, 28°C to 35°C, or 29°C to 32°C. The fermentation temperature can be maintained at, for example, any value or range of 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C, 42°C, 43°C, 45°C, 46°C, 47°C, 48°C, 49°C, 50°C, or between these values. However, those skilled in the art will recognize that the fermentation temperature is not limited to any specific range described herein and can be appropriately modified.
[0083] The pH of the culture medium described herein can be controlled for optimal D-allulose production. The pH of the engineered cell culture or fermentation mixture described herein can be in the range of 3.0 to 7.5. The pH can be maintained at 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.8, 5.0, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 6.0, 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9, 7.0, 7.1, 7.2, 7.3, 7.4, and / or 7.5 for at least a portion of the incubation time. The pH can be maintained in the range between 6.0 and 7.0, 6.2 and 6.7, or 6.3 and 6.6.
[0084] Engineered cells (yeast and / or bacteria) can be cultured for approximately 24 hours to 96+ hours. For example, engineered cells can be cultured for approximately 12 hours, 18 hours, 24 hours, 25 hours, 26 hours, 27 hours, 28 hours, 29 hours, 30 hours, 31 hours, 32 hours, 33 hours, 34 hours, 35 hours, 36 hours, 37 hours, 38 hours, 39 hours, 40 hours, 41 hours, 42 hours, 43 hours, 44 hours, 45 hours, 46 hours, 47 hours, 48 hours, 49 hours, 50 hours, 51 hours, 52 hours, 53 hours, 54 hours, 55 hours, 56 hours, 57 hours, 58 hours, 59 hours, 60 hours, 61 hours, 62 hours, 63 hours, 64 hours, 65 hours, 66 hours, 67 hours, 68 hours, 69 hours, 70 hours, 71 hours, 72 hours, 73 hours, 74 hours, 75 hours, 78 hours, 80 hours, 90 hours, 96 hours, or more than 96 hours. The engineered cells described in this article can be cultured for approximately 48 to 72 hours. A culture (fermentation) time of approximately 48 or 72 hours can be representative of a similar commercial-scale fermentation process. Therefore, the 48-hour or 72-hour time point can be used to compare the fermentation performance of different genetically engineered cell strains.
[0085] Reaction parameters can be measured or adjusted during D-allulose production. Non-limiting examples of reaction parameters include biological parameters (e.g., growth rate, cell size, cell number, cell density, cell type, or cell state), chemical parameters (e.g., pH, redox potential, concentration of reaction substrates and / or products, concentration of dissolved gases such as oxygen and CO2, nutrient concentration, metabolite concentration, ethanol concentration, fermentation substrate concentration, oligopeptide concentration, amino acid concentration, vitamin concentration, hormone concentration, additive concentration, serum concentration, ionic strength, ion concentration, relative humidity, molar concentration, molar osmotic pressure, and other chemicals such as buffers, adjuvants, or reaction byproducts), and physical / mechanical parameters (e.g., density, conductivity, degree of agitation, pressure and flow rate, shear stress, shear rate, viscosity, color, turbidity, light absorption, mixing rate, conversion rate, and thermodynamic parameters such as temperature, light intensity / mass, etc.). Sensors for measuring the parameters described herein are well known to those skilled in the art.
[0086] Fermentation processes can be associated with a variety of characteristics, such as, but not limited to, fermentation production rate, pathway fermentation yield, final titer, and peak fermentation rate. These characteristics can be influenced by the selection of cells (yeast and / or bacteria) and / or genetic modifications of the cells used in the fermentation process. These characteristics can also be influenced by regulating fermentation process conditions. These characteristics can be modulated through a combination of cell selection or modification and the selection of fermentation process conditions.
[0087] The final D-allulose titer can be at least 0.5 g / L, at least 1.0 g / L, at least 2.0 g / L, at least 5 g / L, at least 7.5 g / L, at least 10 g / L, at least 15 g / L, or at least 17.5 g / L.
[0088] Example
[0089] The invention is described in further detail with reference to the following experimental embodiments. Unless otherwise stated, these embodiments are provided for illustrative purposes only and are not intended to be limiting. Therefore, the invention should not in any way be construed as limited to the following embodiments, but should be construed as encompassing any and all variations that become apparent from the teachings provided herein.
[0090] The strain numbering is consistent throughout the examples. For example, strains 1-5 in Example 1 are the same strains as strains 1-5 in Examples 2 and 3.
[0091] Example 1: Genetically modified Saccharomyces cerevisiae strain
[0092] Figure 1 The proposed pathway for the production of D-allulose from sucrose, starch, and / or glucose is shown. In this pathway, glucose and / or fructose are converted to fructose-6-phosphate. Fructose-6-phosphate is converted to D-allulose-6-phosphate by a hexose-6-phosphate epimerase. Finally, D-allulose-6-phosphate is converted to D-allulose by a hexose-6-phosphate phosphatase. To test this pathway and demonstrate the production of D-allulose in genetically engineered yeast (Saccharomyces cerevisiae), the strains described in this and subsequent examples were constructed and tested.
[0093] strain 1-1
[0094] Strain 1-1 is the yeast strain Saccharomyces cerevisiae CEN.PK 113-7D (MATa HIS3 LEU2 TRP1 MAL2-8SUC2; Classification ID: NCBI:txid889517).
[0095] Strain 1-2
[0096] Strain 1-2 is a uracil auxotrophic strain derivative of strain 1-1, with the Aspergillus nidulans amdS gene inserted at the URA3 locus.
[0097] Strains 1-3
[0098] Strains 1-2 were prepared using the Li-acetate method (Gietz, RD et al., "Transformation of yeast by lithium acetate / single-stranded carrier DNA / polyethylene glycol method," Methods Enzymol. 350, 87). Strains 1-3 were generated by transformation with a DNA fragment carrying the sequence of a synthetic transcription factor (sTF; nucleotide sequence SEQ ID NO:185; polypeptide SEQ ID NO:186) and a URA+ marker. The DNA fragment was generated by digesting plasmid B6622 (pK1URA3_TDH3cp-BM3R1-VP16; Rantasalo A. et al., “Synthetic toolkit for complex genetic circuit engineering in Saccharomyces cerevisiae,” ACS Synth.Biol., 2018, 7, 6, 1573-1587) using the restriction endonuclease NotI. Transformants were selected on SDA medium without uracil, and the insertion of sTF was verified by colony PCR, thus generating strains 1-3.
[0099] Strains 1-4
[0100] To generate G418-resistant uracil auxotrophic strains 1-4, the uracil markers in strains 1-3 were replaced with markers that confer resistance to the antibiotic G418, which binds to the LoxP site.
[0101] Strains 1-5
[0102] To generate strains 1-5, strains 1-4 were transformed with a plasmid expressing Cre recombinase, thus removing the G418 resistance cassette from strains 1-4. The resulting strains 1-5 are ura3. - And includes the synthetic transcription factor SEQ ID NO:186 controlled by the TDH3cp promoter.
[0103] strains 1-6 to 1-100
[0104] The polynucleotides encoding D-allulose-6-phosphate 3-epimerase and D-allulose-6-phosphate phosphatase were cloned into the pSCT036 vector (SEQ ID NO: 187). The sequence encoding allulose-6-phosphate 3-epimerase is controlled by the TDH3 promoter (SEQ ID NO: 188), and the sequence encoding allulose-6-phosphate phosphatase is controlled by the promoter of SEQ ID NO: 189, which includes eight synthetic transcription factor (sTF) binding sites for sTF expression in strains 1-5. The plasmids encoding allulose-6-phosphate 3-epimerase and allulose-6-phosphate phosphatase were cloned into parental strains 1-5, as outlined in Table 2.
[0105] Table 2: Genetically modified Saccharomyces cerevisiae strains
[0106]
[0107]
[0108]
[0109]
[0110]
[0111] Example 3: Shake-flask fermentation assay
[0112] Strains 1-5, 1-7 to 1-31, 1-33 to 1-57, 1-99 and 1-100 were run in duplicate in shake flasks to determine D-allulose production.
[0113] The strain was bumped onto synthetic complete medium minus uracil (ScD-ura) plates (6.7 g / L yeast nitrogen without amino acids, 1.9 g / L synthetic complete amino acid mixture, 20 g / L glucose, and 20 g / L agar) and allowed to grow until single colonies formed (2 to 3 days at 30°C or 3 to 5 days at room temperature (approximately 25°C)). Cells from the ScD-ura plates were scraped into sterile seed containers (250 ml Erlenmeyer flasks with baffles) containing 25 ml of ScD-ura and 20 g / L glucose medium (Table 3) and incubated overnight at 30°C, 250 rpm, and 70% humidity. The overnight culture was diluted in 40 ml of DM1u production medium (Table 4) in a 250 ml baffled Erlenmeyer flask to achieve an initial cell density of 0.2 at 600 nm (OD600) and incubated at 30 °C, 250 rpm, and 70% humidity. Optical density was measured at 600 nm and 1 cm path length using a Genesys 20 spectrophotometer (Thermo Scientific). At 72 hours, 1.0 ml of the sample was transferred to a microcentrifuge tube, centrifuged at 14,000 x g for 2 min, and stored at -20 °C until analysis. D-allulose in the sample was analyzed by HPLC. The results are shown in Table 7.
[0114] Table 3: ScD-ura with 20 g / L dextrose
[0115]
[0116] Table 4: DM1u Production Medium - Maltodextrin
[0117]
[0118] GA added before vaccination
[0119] Table 5: Trace Elements at 1000x
[0120]
[0121] Table 6: 1000X DM1 Vitamin Solution
[0122]
[0123] Table 7: Results of the shake flask
[0124]
[0125]
[0126] nd means not detected, below the instrument's detection limit.
[0127] Only one shake flask of strains 1-56 was analyzed.
[0128] Data showed that expression of allulose-6-phosphate phosphatases in SEQ ID NO: 83 and 95 produced almost the same amount of D-allulose as the positive control allulose-6-phosphate phosphatases in SEQ ID NO: 190. However, expression of allulose-6-phosphate phosphatases in SEQ ID NO: 87 and 89 resulted in an increase in D-allulose titers relative to the positive control. Overall, expression of allulose-6-phosphate phosphatases in SEQ ID NO: 15, 19, 23, 25, 35, 37, 39, 43, 45, 49, 59, 63, 77, 83, 85, 87, 89, 91, 93, 95, and 101 had higher D-allulose titers than wild-type strains (1-5) or negative control strains expressing allulose-6-phosphate 3-epimerase in SEQ ID NO: 192 but lacking allulose-6-phosphate phosphatases.
[0129] Example 3: Fermentation determination of flower-shaped plates
[0130] D-allulose production was evaluated by testing strains 1-5, 1-6, 1-32, 1-49, 1-50, 1-58 to 1-98, 1-99 and 1-100 in duplicate.
[0131] The strain was bumped onto ScD-ura plates and grown until single colonies formed (2 to 3 days at 30°C or 3 to 5 days at room temperature (approximately 25°C)). A small piece of biomass was used to inoculate a deep 96-well microtiter plate containing 500 μL of ScD-Ura medium (6.7 g / L amino acid-free yeast nitrogen, 2.0 g / L synthetic complete amino acid mixture, 20 g / L glucose) and incubated for 24 hours at 30°C and 800 RPM in a fixed-track shaker. The overnight culture was transferred to a 48-well flower-shaped plate containing 1000 μL of DMU1 medium (100 g / L maltodextrin and 50 μL GA) to OD600 = 0.2 and incubated for 96 hours at 30°C and 800 RPM in a fixed-track shaker. Samples were taken for HPLC analysis to determine the D-allulose titer. The results are shown in Table 8.
[0132] Table 8: Shaking Bottle Data
[0133]
[0134]
[0135] The results showed that expression of allulose-6-phosphate phosphatases in SEQ ID NO:87 and 145 produced almost the same amount of D-allulose as the positive control allulose-6-phosphate phosphatases in SEQ ID NO:190. However, expression of allulose-6-phosphate phosphatases in SEQ ID NO:89, 87, 183, 179, 173, 169, 149, 89, 137, 131, 127, 123, 121, 119, 117, 115, 113, 107, and 105 caused an increase in the D-allulose titer relative to the positive control. Overall, strains expressing allulose-6-phosphate phosphatases of SEQ ID NO:89, 87, 183, 179, 173, 169, 149, 89, 137, 131, 127, 123, 121, 119, 117, 115, 113, 107, 105, 87, 145, 53, 175, 171, 167, 165, 163, 157, 153, 147, 141, 111, and 109 had higher D-allulose titers than negative control strains expressing allulose-6-phosphate 3-epimerase of SEQ ID NO:192 but lacking allulose-6-phosphate phosphatases.
[0136] Example 4: Genetically modified Kluyveromyces macrocarpa strain
[0137] Figure 1 The proposed pathway for the production of D-allulose from sucrose, starch, and / or glucose is shown. In this pathway, glucose and / or fructose are converted to fructose-6-phosphate. Fructose-6-phosphate is converted to D-allulose-6-phosphate by a hexose-6-phosphate epimerase. Finally, D-allulose-6-phosphate is converted to D-allulose by a hexose-6-phosphate phosphatase. To test this pathway and demonstrate the production of D-allulose in genetically engineered yeast (Kluyveromyces martensii), the strains described in this and subsequent examples were constructed and tested.
[0138] strain 2-1
[0139] Strain 2-1 is a yeast cell, *Kluyveromyces maculae* CD21, deposited at the Belgian Coordinated Collection of Microorganisms / Kouven Catholic University Fungal Collection (BCCMMUCL) 58456.
[0140] strain 2-2
[0141] Strain 2-2 is a uracil auxotrophic derivative of strain 2-1, with the URA3 locus missing.
[0142] strains 2-3 to 2-21
[0143] According to Table 10, strain 2-2 was transformed using the specified transformation fragments (Table 9). The resulting transformants were streaked on ScD-ura plates to isolate single colonies, and single colonies were selected. The selected colonies were evaluated by colony PCR to confirm the integration of the specified sequence. The PCR-validated isolates were named as outlined in Table 10.
[0144] Table 9: Transformed Fragments
[0145]
[0146]
[0147]
[0148] Table 10 :
[0149]
[0150] strain 2-22
[0151] Strain 2-2 was transformed using SEQ ID NO: 198 and 199 (Table 9). The resulting transformants were streaked on ScD-ura plates to isolate single colonies, and these colonies were selected. The selected colonies were evaluated by colony PCR to confirm the integration of the GFP-encoding sequence. The PCR-validated isolates were named strain 2-22.
[0152] Example 5: Shake-flask fermentation determination
[0153] Strains 2-3 to 2-22 were tested to evaluate D-allulose production.
[0154] The strain was bumped onto ScD-ura plates and grown until single colonies formed (overnight at 30°C or 2-3 days at room temperature (approximately 25°C)). Cells from the ScD-ura plates were scraped into sterile seed containers (250 ml baffled Erlenmeyer flasks) containing 25 ml of ScD-ura and 20 g / L glucose medium (Table 3) and incubated overnight at 30°C, 250 rpm, and 70% humidity. The overnight culture was diluted in 40 ml of ScD-Ura production medium (Table 3) in a 250 ml baffled Erlenmeyer flask to achieve an initial cell density of OD600 = 0.2 and incubated at 30°C, 250 rpm, and 70% humidity. At 72 hours, 0.5 ml of the sample was transferred to a microcentrifuge tube, centrifuged at 14,000 x g for 2 minutes, and stored at -20°C until analysis. D-allulose in the sample was analyzed by HPLC. The results are shown in Table 11.
[0155] Table 11: Results of 72-hour shaking flask operation
[0156]
[0157]
[0158] nd means not detected, below the instrument's detection limit.
[0159] The results showed that multiple promoters and terminators were suitable for the expression of epimerase and allulose-6-phosphate phosphatase in *Kluyveromyces martensii* to produce D-allulose.
[0160] Example 6: Shaking Flask Test
[0161] Strains 2-3 to 2-22 were tested to evaluate D-allulose production.
[0162] The strain was bumped onto ScD-ura plates and grown until single colonies formed (overnight at 30°C or 2-3 days at room temperature (approximately 25°C)). Cells from the ScD-ura plates were scraped into sterile seed containers (250 ml baffled Erlenmeyer flasks) containing 25 ml of ScD-ura and 20 g / L glucose medium (Table 3) and incubated overnight at 30°C, 250 rpm, and 70% humidity. The overnight culture was diluted in 40 ml of DM1u production medium (Table 4) in 250 ml baffled Erlenmeyer flasks to achieve an initial cell density of OD600 = 0.2 and incubated at 30°C, 250 rpm, and 70% humidity. At 72 hours, 0.5 ml of the sample was transferred to a microcentrifuge tube, centrifuged at 14,000 x g for 2 minutes, and stored at -20°C until analysis. D-allulose in the sample was analyzed by HPLC. The results are shown in Table 12.
[0163] Table 12: Results of 72-hour shaking flask operation
[0164]
[0165]
[0166] nd means not detected, below the instrument's detection limit.
[0167] The results showed that a variety of promoters and terminators were suitable for the expression of epimerase and allulose-6-phosphate phosphatase in *Kluyveromyces martensii* to produce D-allulose.
[0168] Example 7: Genetically modified Kluyveromyces macrocarpa strain
[0169] strain 2-23
[0170] Strain 2-2 was transformed with SEQ ID NO:239. The resulting transformants were streaked onto ScD-ura plates to isolate single colonies, which were then selected. SEQ ID NO:239 contained the TDH3 promoter (SEQ ID NO:222), the gene encoding allulose-6-phosphate epimerase (SEQ ID NO:192), the Cyc terminator (SEQ ID NO:218), the PGK promoter (SEQ ID NO:223), the gene encoding allulose-6-phosphate phosphatase (SEQ ID NO:190), the PDC_Lue2 terminator (SEQ ID NO:225), and the ScURA3 selection marker cassette. Selected colonies were evaluated by colony PCR to confirm the integration of the specified sequences. The PCR-validated isolates were named strain 2-23.
[0171] Strain 2-24
[0172] Strain 2-2 was transformed using SEQ ID NO: 203 and SEQ ID NO: 237. SEQ ID NO: 237 contains the 3' portion of the ScURA3 selection marker (SEQ ID NO: 214), the ScURA3 terminator (SEQ ID NO: 217), the KmTDH3 promoter (SEQ ID NO: 222), the gene encoding allulose-6-phosphate phosphatase (SEQ ID NO: 105), the KmPGK1 terminator, and the 3' KmCYB2 flanking sequence (SEQ ID NO: 213). The resulting transformants were streaked on ScD-ura plates to isolate single colonies, and these colonies were selected. The selected colonies were evaluated by colony PCR to confirm the integration of the specified sequences. The PCR-validated isolates were named strain 2-24.
[0173] Strain 2-25
[0174] Strain 2-2 was transformed using SEQ ID NO: 203 and SEQ ID NO: 238. SEQ ID NO: 238 contains the 3' portion of the ScURA3 selection marker (SEQ ID NO: 214), the ScURA3 terminator (SEQ ID NO: 217), the KmTDH3 promoter (SEQ ID NO: 222), the gene encoding allulose-6-phosphate phosphatase (SEQ ID NO: 107), the KmPGK1 terminator, and the 3' KmCYB2 flanking sequence (SEQ ID NO: 213). The resulting transformants were streaked on ScD-ura plates to isolate single colonies, and these colonies were selected. The selected colonies were evaluated by colony PCR to confirm the integration of the specified sequences. The PCR-validated isolates were named strain 2-25.
[0175] Example 8: Measurement of Flower-Shaped Plates
[0176] The D-allulose production of strains 2-3, 2-14, 2-23, 2-24, and 2-25 was evaluated.
[0177] The strain was bumped onto ScD-ura plates and allowed to grow until single colonies formed (2 to 3 days at 30°C or 3 to 5 days at room temperature (approximately 25°C)). A small piece of biomass was used to inoculate a 250 mL baffled flask containing 40 mL of buffered ScD-Ura medium (6.7 g / L amino acid-free yeast nitrogen, 1.9 g / L synthetic complete amino acid mixture, 100 g / L glucose, 19.5 g / L MES buffer, pH adjusted to 6.0) and incubated for 24 hours at 30°C and 250 RPM in a shaker. 40 μL of the overnight culture was transferred to 48-well flower-shaped plates containing 1000 μL of (i) buffered ScD-Ura with glucose, (ii) ScD-Ura with maltodextrin, or (ii) DMu1 medium (Table 4) and incubated for 92 hours at 30°C and 800 RPM in a shaker. Samples were taken for HPLC analysis to determine the D-allulose titer. Due to the presence of small peak artifacts in the HPLC data, some samples were also tested by high-performance ion chromatography. The results are shown in Table 13.
[0178] Table 13.
[0179]
[0180]
[0181] nt = Untested
[0182] Example 9: Shake-flask fermentation determination
[0183] The D-allulose production of strains 2-23, 2-3, 2-24, and 2-25 was evaluated.
[0184] The strain was bumped onto ScD-ura plates and grown until single colonies formed (overnight at 30°C or 2-3 days at room temperature (approximately 25°C)). Cells from the ScD-ura plates were scraped into sterile seed containers (250 ml baffled Erlenmeyer flasks) containing 25 ml of ScD-ura and 20 g / L glucose medium (Table 3) and incubated overnight at 30°C, 250 rpm, and 70% humidity. The overnight culture was diluted in 40 ml of fermentation medium (summarized in Table 18, indicating changes relative to the basal medium) in 250 ml baffled Erlenmeyer flasks to achieve an initial cell density of OD600 = 0.1 and incubated at 30°C and RPM as specified in Table 17, and 70% humidity. At 236 hours, 0.5 ml of the sample was transferred to a microcentrifuge tube, centrifuged at 14,000 x g for 2 minutes, and stored at -20°C until analysis. The D-allulose in the samples was analyzed by HPLC. The results are shown in Table 14.
[0185] Overall, the results indicate that strain 2-24 produced the highest allulose titer under the tested conditions. Compared to strains 2-3 or 2-23, which expressed both allulose-6-phosphate epimerase (SEQ ID NO:192) and allulose-6-phosphate phosphatase (SEQ ID NO:190), strains 2-14, 2-24, and 2-25, which all expressed allulose-6-phosphate epimerase (SEQ ID NO:194) and allulose-6-phosphate phosphatases (SEQ ID NO:123, 105, and 107), all produced higher D-allulose titers. The data also showed that the tested strains produced D-allulose from multiple feedstocks in different fermentation media. The results demonstrate that the effects of both RPM and baffle size are media-dependent. For example, higher RPM and larger baffles are beneficial for production in Sc-Ura + glucose medium (i.e., higher D-allulose titers), neutral in Sc-Ura + maltodextrin medium, and detrimental in DMu1 medium. However, even with this variability, all tested conditions produced D-allulose, demonstrating that a variety of media, substrates, and conditions are suitable for D-allulose fermentation.
[0186] Table 14.
[0187]
[0188]
[0189] Due to the presence of small peak artifacts during HPLC analysis, the fermentation broth from strain 2-24 was further analyzed by high-pressure ion chromatography (HPIC) (Experiments 10.4, 10.9, 10.14, 10.19, 10.24, 10.29, 10.32, 10.34 and 10.36), and the results are reported in Table 15.
[0190] Table 15.
[0191]
[0192]
[0193] Example 10: PFK1 deletion in Kluyveromyces martensii
[0194] PFK1 is an enzyme in the glycolysis pathway and represents the first irreversible reaction specific to this pathway. Unbound by any particular theory, method, or mode of action, when PFK1 activity is reduced or eliminated, more cellular fructose-6-phosphate can be used to produce D-allulose. To test this pathway and demonstrate increased D-allulose production in genetically engineered yeast (Kluyveromyces martensii), strain 2-26 was constructed and tested.
[0195] Strain 2-26
[0196] Strain 2-2 was transformed using SEQ ID NO: 240 and SEQ ID NO: 241. SEQ ID NO: 240 contains the 3' portion of the ScURA3 selection marker (SEQ ID NO: 214), the ScURA3 terminator (SEQ ID NO: 217), the KmTDH3 promoter (SEQ ID NO: 222), the gene encoding allulose-6-phosphate phosphatase (SEQ ID NO: 105), the KmPGK1 terminator, and the 3' PFK1 flanking sequence (SEQ ID NO: 242). SEQ ID NO:241 contains a 5' PFK1 flanking sequence (SEQ ID NO:243), the ScPDC1 promoter (SEQ ID NO:220), the gene encoding allulose-6-phosphate epimerase (SEQ ID NO:194), the KmGPM1 terminator (SEQ ID NO:221), the ScURA3 promoter (SEQ ID NO:216), and the 5' portion of the ScURA3 selection marker (SEQ ID NO:215). The resulting transformants were streaked on ScD-ura plates to isolate single colonies, which were then selected. The selected colonies were evaluated by colony PCR to confirm the integration of the specified sequence. The PCR-validated isolates were named strain 2-26.
[0197] Cells from strains 2-23, 2-24, and 2-26 were evaluated for D-allulose production. The strains were bumped onto ScD-ura plates and allowed to grow until single colonies formed (1 to 3 days at 30°C or 2 to 5 days at room temperature (approximately 25°C)). Cells from the ScD-ura plates were scraped into sterile seed containers (250 ml Erlenmeyer flasks with baffles) containing 50 ml of ScD-ura and 20 g / L glucose medium (Table 3) and incubated overnight at 30°C, 250 rpm, and 70% humidity. The overnight culture was diluted in 40 ml of fermentation medium ((i) ScD-ura with a total of 200 g / L glucose or (ii) DM1u in which maltodextrin is replaced with 200 g / L glucose, as specified in Table 16) in a 250 ml baffled Erlenmeyer flask to achieve an initial cell density of OD600 = 0.1 and incubated at 30 °C, 250 rpm, and 70% humidity. At 93 h, 0.5 ml of the sample was transferred to a microcentrifuge tube, centrifuged at 14,000 x g for 2 min, and the supernatant was collected and stored at -20 °C until analysis. The D-allulose content of the sample was analyzed by HPLC and HPIC. The results are shown in Table 16.
[0198] Compared to its equivalent strain (strain 2-24) where the PFK1 gene was not deleted, strain 2-26 (with the natural *Kluyveromyces martensii* PFK1 gene deleted) showed a significant increase in D-allulose production. In ScD-Ura medium, measured by HPLC, the D-allulose titer from strain 2-26 was approximately 15 g / L, compared to approximately 5.5 g / L in strain 2-24, showing an almost 3-fold increase. In DM1u medium, measured by HPLC, strain 2-26 produced approximately 38 g / L of D-allulose, compared to approximately 3 g / L in strain 2-24, representing an almost 17-fold increase. The D-allulose titer from strain 2-26 was also significantly higher than that of the control strain 2-23. The same trend was observed in HPIC measurements, with increased D-allulose titers in both ScD-Ura (approximately 3-fold increase) and DM1u (more than 4-fold increase) media. Although the values measured by HPIC were lower, this was due to peak artifacts on HPLC, and the overall trend of PFK1 deficiency significantly increasing D-allulose titers remained consistent across various culture medium conditions and measurement methods. For example, the D-allulose titer from strain 2-26, measured by HPIC, was also much higher than that of the control strain 2-23.
[0199] Table 16.
[0200]
[0201]
[0202] nd- Not detected
[0203] Example 11: PFK1 deficiency in Saccharomyces cerevisiae
[0204] PFK1 is an enzyme in the glycolysis pathway and represents the first irreversible reaction specific to glycolysis. Unbound by any particular theory, method, or mode of action, when PFK1 activity is reduced or eliminated, more cellular fructose-6-phosphate can be used to produce D-allulose. To test this pathway and demonstrate increased D-allulose production in genetically engineered yeast (Saccharomyces cerevisiae), the strains outlined below were constructed and tested.
[0205] strain 4-1
[0206] Strain 4-1 is a Saccharomyces cerevisiae strain BY4741 (USC Accession No. 4040002), which is a deletion strain derived from Saccharomyces cerevisiae strain S288C (USC Accession No. 204508), which lacks commonly used genes, including PFK1.
[0207] strain 4-2
[0208] The upstream (SEQ ID NO:246) and downstream (SEQ ID NO:247) sequences were used to amplify the PFK1 deletion site in strain 4-1. This amplification product was then cloned into strain 1-58 to delete the PFK1 gene. This produced a strain with PFK1 knockout and consecutive nucleic acid sequences encoding allulose-6-phosphate epimerase (SEQ ID NO:192) and allulose-6-phosphate phosphatase (SEQ ID NO:105). This strain was named strain 4-2.
[0209] The D-allulose production of strains 1-58, 1-67, and 4-2 was determined. The strains were bumped onto synthetic complete medium minus uracil (ScD-ura) plates (6.7 g / L amino acid-free yeast nitrogen, 1.9 g / L synthetic complete amino acid mixture, 20 g / L glucose, and 20 g / L agar) and allowed to grow until single colonies formed (2 to 3 days at 30°C or 3 to 5 days at room temperature (approximately 25°C)). Cells from the ScD-ura plates were scraped into sterile seed containers (250 ml baffled Erlenmeyer flasks) containing 25 ml of ScD-ura and 20 g / L glucose medium (Table 3) and incubated overnight at 30°C, 250 rpm, and 70% humidity. The overnight culture was diluted in 40 ml of DM1u production medium (variations of maltodextrin and GA concentrations are shown in Table 17) in a 250 ml baffled Erlenmeyer flask to achieve an initial cell density of 0.2 at 600 nm (OD600) and incubated at 30 °C, 250 rpm, and 70% humidity. Optical density was measured at 600 nm and 1 cm path length using a Genesys 20 spectrophotometer (Thermo Fisher Scientific). At 24, 90, 114, 162, 192, and 239 hours, 1.0 ml samples were transferred to microcentrifuge tubes, centrifuged at 14,000 x g for 2 min, and stored at -20 °C until analysis. D-allulose in the samples was analyzed by HPLC. The results are shown in Table 17.
[0210] Overall, the deletion of the PFK1 gene in *Saccharomyces cerevisiae* (strains 4-2) did not increase the production of D-allulose compared to equivalent strains (strains 1-58) without the deletion. In fact, under certain conditions, the D-allulose production in PFK1-deleted strains was lower than that in equivalent strains.
[0211] Table 17.
[0212]
[0213] PCT / RO / 134 Table
Claims
1. A genetically engineered Kluyveromyces macrocarpa cell capable of producing D-allulose, said engineered cell comprising: Deletion or disruption of the natural phosphofructokinase-1 (PFK1) gene; The exogenous polynucleotide sequence of allulose-6-phosphate phosphatase that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, 115, 83, 95, 113, 117, 119, 121, 127, 131, 137, 145, 169, 173, 179, and 183; and The exogenous polynucleotide sequence encoding at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO: 192, 194, and 196.
2. The engineered cell according to claim 1, wherein the allulose-6-phosphate 3-epimerase is at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO: 192, 194, and 196.
3. The engineered cell according to claim 1 or claim 2, wherein the allulose-6-phosphate phosphatase is at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, 115, 83, 95, 113, 117, 119, 121, 127, 131, 137, 145, 169, 173, 179, and 183; The allulose-6-phosphate phosphatase described therein is at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, and 115; The allulose-6-phosphate phosphatase described therein is at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO: 87, 89, and 190; or The allulose-6-phosphate phosphatase described therein is at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to at least one of SEQ ID NO:87 and 89.
4. The engineered cell according to any of the preceding claims, wherein... The allulose-6-phosphate 3-epimerase is at least 85% or at least 90% identical to at least one of SEQ ID NO: 192, 194 and 196; and / or The allulose-6-phosphate phosphatase is at least 85% or at least 90% identical to at least one of SEQ ID NO:87, 89, 190, 123, 105, 107 and 115.
5. The engineered cell according to any of the preceding claims, The allulose-6-phosphate 3-epimerase is at least 90% identical to at least one of SEQ ID NO: 192, 194 and 196; and / or The allulose-6-phosphate phosphatase is at least 90% identical to at least one of SEQ ID NO:87 and 89.
6. The engineered cell according to any of the preceding claims, wherein... The natural PFK1 gene encodes a PFK1 enzyme that is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to that in SEQ ID NO:244; The natural PFK1 gene encodes a PFK1 enzyme that is at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to that in SEQ ID NO:244; and / or The natural PFK1 gene encodes a PFK1 enzyme that is at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to that in SEQ ID NO:
244.
7. The engineered cell according to any of the preceding claims, The natural PFK1 gene therein is at least 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to SEQ ID NO:245; The natural PFK1 gene thereon is at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to SEQ ID NO:245; and / or The natural PFK1 gene thereon is at least 90%, at least 95%, at least 97%, at least 99%, or 100% identical to SEQ ID NO:
245.
8. The engineered cell according to any of the preceding claims, wherein the allulose-6-phosphate 3-epimerase is at least 80%, at least 85%, at least 90%, or at least 95% identical to at least one of SEQ ID NO: 192, 194, and 196; wherein the allulose-6-phosphate phosphatase is at least 80%, at least 85%, at least 90%, or at least 95% identical to at least one of SEQ ID NO: 87, 89, 190, 123, 105, 107, and 115; and wherein the cell is capable of producing at least 10 g / L D-allulose.
9. The engineered cell according to any of the preceding claims, wherein the allulose-6-phosphate 3-epimerase is at least 80%, at least 85%, at least 90%, or at least 95% identical to SEQ ID NO:194; wherein the allulose-6-phosphate phosphatase is at least 80%, at least 85%, at least 90%, or at least 95% identical to SEQ ID NO:105; and wherein the cell is capable of producing at least 10 g / L D-allulose.
10. The engineered cell according to any of the preceding claims, wherein one or more of the exogenous polynucleotide sequences are operatively linked to a heterologous promoter and / or a heterologous terminator.
11. The engineered cell of claim 10, wherein the promoter is selected from the group consisting of: pyruvate decarboxylase promoter (PDCp), translation elongation factor 2 promoter (TEF2p), SED1 promoter, alcohol dehydrogenase 1A promoter (ADH1p), hexokinase 2 promoter (HXK2p), FLO5 promoter, pyruvate kinase 1 promoter (PYK1p); 6-phosphogluconic acid dehydrogenase promoter (6PGDp); glyceraldehyde-3-phosphate dehydrogenase promoter (TDH3p); translation elongation factor 1 promoter (TEF1p); phosphoglucose mutase 1 promoter (PGM1p); 3-phosphoglycerate kinase promoter (PGK1p); enolase promoter (ENO1p); asparagine synthase promoter (ASNSp); 50S ribosomal protein L1 promoter (RPLAp); RPL16B; and PDC1 promoter.
12. The engineered cell according to claim 10 or 11, wherein the terminator is selected from the group consisting of: GAL10 terminator, PDC terminator, transaldolase terminator (TAL), 6PGD terminator (6PGDt); ASNS terminator (ASNSt); ENO1 terminator (ENO1t); hexokinase 1 terminator (HXK1t); PGK1 terminator (PGK1t); PGM1 terminator (PGM1t); PYK1 terminator (PYK1t); RPLA terminator (RPLAt); transaldolase 1 terminator (TAL1t); TDH3 terminator (TDH3t); translation elongation factor 2 terminator (TEF2t); triose phosphate isomerase 1 terminator (TPI1t); TEF1; iso-1-cytochrome c terminator (CYC1); HXK2 terminator; GPM1 terminator; URA3 terminator; ADH1 terminator; and ScGAL10 terminator.
13. A method for producing D-allulose, the method comprising: The substrate is contacted with engineered cells according to any of the preceding claims, wherein the engineered cells produce at least 1.0 g / L, at least 5.0 g / L, at least 10.0 g / L, or at least 15 g / L after 72 hours.
14. The method of claim 13, wherein the substrate comprises starch, glucose, cellulose biomass, or combinations thereof.
15. Use of engineered cells according to any one of claims 1 to 12 for the production of D-allulose.
